Q4 2024 Management View CEO Eef Schimmelpennink highlighted 2024 as a transformative year, marked by significant milestones, including the completion of the Phase 3 CLARITY study, submission and ...

New Drug Application (NDA) for LNZ100 for treatment of presbyopia on track for PDUFA target action date of August 8, 2025Upon FDA approval, ...

TD Cowen analyst Stacy Ku initiated coverage of Lenz Therapeutics (LENZ) with a Buy rating and $60 price target The firm cites conviction in ...

Learn about when to start wearing reading glasses depending on age and vision changes, and explore the top five brands to ...

Please provide your email address to receive an email when new articles are posted on . Few conditions impact as many people worldwide as presbyopia. Recent estimates have placed the prevalence of ...

ATHENS, Greece — Allogenic corneal inlays can be a safe solution for mild hyperopia and emmetropic presbyopia, according to an expert at the ESCRS winter meeting. The FDA granted fast track ...

Presbyopia is caused by a stiffening in the lens of the eye that develops in people after the age of 40, and affects an estimated 128 million people in the US. AbbVie is recommending Vuity ...

Developments include low-dose atropine eye drops and LASIK procedures. The global myopia and presbyopia treatment market is projected to reach a value of $32.74b by 2030 at a compound annual ...

The FDA has approved the first and so far only pharmacological treatment for presbyopia, a sight condition that typically starts in middle age and involves difficulty in focusing on near objects ...

As we age, many changes occur within our bodies, including a gradual decline in our reading vision, known as presbyopia. This natural process, which typically begins in our 40s, can lead to ...